Innovius Bio Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.64 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
About Innovius Bio Pharmaceutical
Innovius Bio Pharmaceutical Private Limited (IBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2016 (Eight years and eight months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.64 M, as per Ministry of Corporate Affairs (MCA) records.
Turaga Kamaraju, Venkateswara Narayana, and Senapathi Jagadeesh serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG2016PTC109778
-
Company No.
109778
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 2016
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Innovius Bio Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Turaga Kamaraju
|
Additional Director | 06-Sep-2017 | Current |
|
Venkateswara Narayana
|
Director | 22-Nov-2017 | Current |
|
Senapathi Jagadeesh
|
Director | 15-May-2018 | Current |
Financial Performance of Innovius Bio Pharmaceutical.
Innovius Bio Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovius Bio Pharmaceutical?
In 2017, Innovius Bio Pharmaceutical had a promoter holding of 50.62% and a public holding of 49.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Max Cinemas Hyderabad LlpVenkateswara Narayana is a mutual person
-
Applied Academy Private Limited
Senapathi Jagadeesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovius Bio Pharmaceutical?
Unlock and access historical data on people associated with Innovius Bio Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovius Bio Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovius Bio Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
